24.08
-0.22 (-0.88%)
| Penutupan Terdahulu | 24.30 |
| Buka | 22.90 |
| Jumlah Dagangan | 18,271 |
| Purata Dagangan (3B) | 12,145 |
| Modal Pasaran | 42,188,328 |
| Harga / Jualan (P/S) | 1.79 |
| Harga / Buku (P/B) | 3.38 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 11 Aug 2025 - 15 Aug 2025 |
| Margin Keuntungan | -15.45% |
| Margin Operasi (TTM) | -17.43% |
| EPS Cair (TTM) | -2.06 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 43.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 19.09% |
| Nisbah Semasa (MRQ) | 0.760 |
| Aliran Tunai Operasi (OCF TTM) | 1.06 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.76 M |
| Pulangan Atas Aset (ROA TTM) | -10.90% |
| Pulangan Atas Ekuiti (ROE TTM) | -25.29% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Precipio, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | -3.5 |
| Osilator Teknikal | 4.0 |
| Purata | -1.00 |
|
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 14.13% |
| % Dimiliki oleh Institusi | 7.46% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 23 Jan 2026 | Pengumuman | DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event |
| 15 Jan 2026 | Pengumuman | Precipio Takes Major Steps Toward a Clean Balance Sheet |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |